Literature DB >> 25820052

Inappropriate shock for myopotential over-sensing in a patient with subcutaneous ICD.

Alessandro Corzani1, Matteo Ziacchi2, Mauro Biffi2, Igor Diemberger2, Cristian Martignani2, Giuseppe Boriani2.   

Abstract

Inappropriate ICD shocks are common adverse events; they are mainly due to supraventricular arrhythmias and secondly are related to noise, undersensing, oversensing, device malfunctions. We present a case of inappropriate device therapy due to myopotential oversensing in a patient with a subcutaneous ICD (s-ICD). A 58 years old male with an s-ICD during the device interrogation showed a previous episode of suspected sustained ventricular tachycardia at 210 bpm, which was effectively treated with ICD shock. The patient experienced the electrical shock while holding a big gas-cylinder in his arms. The EGM analysis revealed many irregular ventricular signals of low amplitude lasting for 24 s and interrupted by the shock. The device showed no malfunctions. This is the first case report of inappropriate S-ICD shock related to myopotential over-sensing. By recording intracardiac EGM, we demonstrated that the noise was created by the activity of the pectorals muscles.
Copyright © 2015 Cardiological Society of India. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Device inappropriate shocks; Implantable cardioverter defibrillators; Myopotential over-sensing; Subcutaneous ICD; Ventricular tachyarrhythmia

Mesh:

Year:  2015        PMID: 25820052      PMCID: PMC4382521          DOI: 10.1016/j.ihj.2015.01.001

Source DB:  PubMed          Journal:  Indian Heart J        ISSN: 0019-4832


  11 in total

1.  Inappropriate implantable cardioverter-defibrillator therapy due to the detection of premature ventricular complexes.

Authors:  J J Goldberger; G Horvath; R Challapalli; A H Kadish
Journal:  Pacing Clin Electrophysiol       Date:  1999-05       Impact factor: 1.976

2.  Inappropriate discharges from an intravenous implantable cardioverter defibrillator due to T-wave oversensing.

Authors:  T Washizuka; M Chinushi; H Kasai; H Watanabe; M Tagawa; Y Hosaka; A Abe; Y Aizawa
Journal:  Jpn Circ J       Date:  2001-07

3.  Limitations and late complications of third-generation automatic cardioverter-defibrillators.

Authors:  S O Nunain; M Roelke; T Trouton; S Osswald; Y H Kim; G Sosa-Suarez; D R Brooks; B McGovern; M Guy; D F Torchiana
Journal:  Circulation       Date:  1995-04-15       Impact factor: 29.690

4.  BIVentricular versus right ventricular antitachycardia pacing to terminate ventricular tachyarrhythmias in patients receiving cardiac resynchronization therapy: the ADVANCE CRT-D Trial.

Authors:  Maurizio Gasparini; Frédéric Anselme; Jacques Clementy; Massimo Santini; José Martínez-Ferrer; Tiziana De Santo; Elisabetta Santi; Jeorg O Schwab
Journal:  Am Heart J       Date:  2010-06       Impact factor: 4.749

5.  Risk factors for appropriate cardioverter-defibrillator shocks, inappropriate cardioverter-defibrillator shocks, and time to mortality in 549 patients with heart failure.

Authors:  Harit Desai; Wilbert S Aronow; Chul Ahn; Kaushang Gandhi; Sadaf Hussain; Hoang M Lai; Mala Sharma; William H Frishman; Martin Cohen; Carmine Sorbera
Journal:  Am J Cardiol       Date:  2010-03-11       Impact factor: 2.778

6.  Prospective comparison of discrimination algorithms to prevent inappropriate ICD therapy: primary results of the Rhythm ID Going Head to Head Trial.

Authors:  Michael R Gold; Saleem Ahmad; Kevin Browne; Kellie Chase Berg; Lisa Thackeray; Ronald D Berger
Journal:  Heart Rhythm       Date:  2011-10-04       Impact factor: 6.343

7.  Noise, artifact, and oversensing related inappropriate ICD shock evaluation: ALTITUDE noise study.

Authors:  Brian D Powell; Samuel J Asirvatham; David L Perschbacher; Paul W Jones; Yong-Mei Cha; David A Cesario; Michael Cao; F Roosevelt Gilliam; Leslie A Saxon
Journal:  Pacing Clin Electrophysiol       Date:  2012-04-22       Impact factor: 1.976

8.  Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact.

Authors:  James P Daubert; Wojciech Zareba; David S Cannom; Scott McNitt; Spencer Z Rosero; Paul Wang; Claudio Schuger; Jonathan S Steinberg; Steven L Higgins; David J Wilber; Helmut Klein; Mark L Andrews; W Jackson Hall; Arthur J Moss
Journal:  J Am Coll Cardiol       Date:  2008-04-08       Impact factor: 24.094

9.  Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study.

Authors:  Bruce L Wilkoff; Brian D Williamson; Richard S Stern; Stephen L Moore; Fei Lu; Sung W Lee; Ulrika M Birgersdotter-Green; Mark S Wathen; Isabelle C Van Gelder; Brooke M Heubner; Mark L Brown; Keith K Holloman
Journal:  J Am Coll Cardiol       Date:  2008-08-12       Impact factor: 24.094

10.  Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the EFFORTLESS S-ICD Registry.

Authors:  Pier D Lambiase; Craig Barr; Dominic A M J Theuns; Reinoud Knops; Petr Neuzil; Jens Brock Johansen; Margaret Hood; Susanne Pedersen; Stefan Kääb; Francis Murgatroyd; Helen L Reeve; Nathan Carter; Lucas Boersma
Journal:  Eur Heart J       Date:  2014-03-26       Impact factor: 29.983

View more
  4 in total

1.  Surface electromyography of myopotential oversensing provoked by simultaneous straining and leftward twisting in a patient with an implantable cardioverter defibrillator.

Authors:  Yoichi Ajiro; Tsuyoshi Shiga; Morio Shoda; Nobuhisa Hagiwara
Journal:  Heart Vessels       Date:  2016-08-30       Impact factor: 2.037

2.  Changing place, changing future: Repositioning a subcutaneous implantable cardioverter-defibrillator can resolve inappropriate shocks secondary to myopotential oversensing.

Authors:  Paola Berne; Graziana Viola; Giovanni Motta; Nicola Marziliano; Valerio Carboni; Gavino Casu
Journal:  HeartRhythm Case Rep       Date:  2017-08-01

3.  An "UninTENSional" Subcutaneous Implantable Cardioverter-defibrillator Shock.

Authors:  Suzette L Turner; Sheldon M Singh
Journal:  J Innov Card Rhythm Manag       Date:  2018-11-15

4.  Subcutaneous Implantable Cardioverter-Defibrillator in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: A Transatlantic Experience.

Authors:  Gabriela M Orgeron; Aditya Bhonsale; Federico Migliore; Cynthia A James; Crystal Tichnell; Brittney Murray; Emanuele Bertaglia; Julia Cadrin-Tourigny; Pietro De Franceschi; Jane Crosson; Harikrishna Tandri; Domenico Corrado; Hugh Calkins
Journal:  J Am Heart Assoc       Date:  2018-11-06       Impact factor: 5.501

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.